Cancer drug is not worth a lot more than the DRAM business. First, DRAM can be produced at once without waiting another 5 to 7 years before it run the gamuts of testing. Second, I doubt that there is going to be a single "miracle" drug for all cancers. A method , maybe, but that method of treatment will probably need to be customized for each patient (and for each different cancer). That is my opinion, and I have been trying to do something about new approaches for 20 years, wasted a lot of good money and finally gave up (g). In essence, a small pharmacological microplant at the bed side of each patient, producing exactly the "thingy" (and I don't want to go into gory details here, it is after all a mixed company) that the specific cancer "hate most".
Market Data 
Markets 
AI
